Open AccessAbstract 2860: 89Zr-trastuzumab immunoPET imaging to monitor src status after treatment in HER2 breast cancer
Author(s) -
Brooke N. McKnight,
Nerissa Viola-Villegas
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-2860
Subject(s) - trastuzumab , breast cancer , dasatinib , medicine , proto oncogene tyrosine protein kinase src , cancer , positron emission tomography , monoclonal antibody , cancer research , nuclear medicine , oncology , antibody , immunology , receptor , tyrosine kinase